Danone North America Announces the FDA’s Decision on Their Petition for the First-Ever Qualified Health Claim for Yogurt, Linking This Dairy Aisle Staple to a Reduced Risk of Type 2 Diabetes

Our Bureau

In response to a petition submitted by food and beverage leader Danone North America, the U.S. Food and Drug Administration (FDA) today announced the first-ever qualified health claim for yogurt, recognizing a potential link between its regular consumption and a reduced risk of type 2 diabetes, and giving consumers another compelling […]

The 16th Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM Takes Place in Nanyang, China 

Our Bureau

Co-hosted by the Nanyang Chinese Medicine Development Bureau, the China Association of Chinese Medicine (CACM) and the China Association of Traditional Chinese Medicine (CATCM), the Zhang Zhongjing Medicine Culture Festival & Forum on High-quality Development of TCM was held in Nanyang, China from February 26th to 28th. Themed “Promote the International, Industrialized, and Modernized Development […]

BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024

Our Bureau

BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced two upcoming presentations at the International Conference on Alzheimer’s and Parkinson’s Diseases 2024 (AD/PD™ 2024) to be held March 5-9, 2024 in Lisbon, Portugal. […]

Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF

Our Bureau

Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on meeting the significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead, late-clinical stage product candidate and innovative therapeutic and diagnostic products, today highlighted that its FemaSeed intratubal insemination product, a revolutionary approach to […]

Philips extends leadership in virtually helium-free MRI with more than 1,000 systems installed, expanding patient access worldwide

Our Bureau

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a significant milestone as it expands access to virtually helium-free [1] MRI to more patients in more places, with more than 1,000 systems now installed worldwide. As healthcare providers strive to deliver high-quality care to patients, at #ECR2024 Philips […]

Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis

Our Bureau

Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, continues to make a distinctive, steadfast and positive impact on the widespread and complex mental health crisis through one of the company’s bedrock […]

M3 launches Doctors.net.uk: ‘Pathway’ to Support International Medical Graduates Relocating to the UK’

Our Bureau

M3 (EU) has announced the international launch of ‘Doctors.net.uk: Pathway’, the latest addition to Doctors.net.uk, the UK’s leading online community of more than 250,000 GMC-registered doctors. M3 (EU) recently unveiled the new, exclusive online platform, which is designed to provide comprehensive support for overseas doctors seeking to practice in the […]

Subscribe Now